Dublin, Nov. 14, 2024 (GLOBE NEWSWIRE) -- The "High Potency API Contract Manufacturing Market Size, Share & Trends Analysis by Product (Innovative, Generic), Dosage Form (Injectable, Creams), Application, Synthesis, and Region, 2025-2030" report has been added to ResearchAndMarkets.com's offering.
The global high potency API contract manufacturing market size is expected to reach USD 14.87 billion by 2030, registering a CAGR of 10.98% over the forecast period. The main drivers of this market are rising demand for oncology drugs, advancements in manufacturing technology, and a rise in capacity to meet the increasing demand. Also, a rise in target therapies to cure chronic diseases is going to accelerate industry growth. The COVID-19 pandemic boosted the demand for high potency APIs (HPAPIs).
However, during the second half, the industry started to gain importance due to a rise in demand for vaccines to fight the coronavirus. This rise has also increased the demand for raw materials and product intermediates of API molecules. Moreover, the growing demand for HPAPI molecules during the COVID-19 pandemic has led to the price hike of the same, thus boosting revenue growth in 2020 and 2021. There has been a rise in the outsourcing activities of high potency active pharmaceuticals as it removes the need for investment in expensive infrastructure for containing it.
Also, the installation & maintenance of the facility is complex and requires specialized engineers. The high cost of producing high potency API in-house, combined with the pressure to produce affordable drugs, has significantly contributed to the increasing outsourcing activities by companies. A wide range of outsourcing providers offers HPAPI services, thus making it difficult for companies to choose an appropriate CDMO. The large-scale CDMOs become the most likely choice as they provide large volumes. However, due to the small volumes required for dosage, small-scale providers are also gaining importance.
High Potency API Contract Manufacturing Market Report Highlights
- The product type segment is classified into innovative and generic. The innovative segment accounted for the largest revenue share in 2024
- Based on applications, the oncology segment dominated the industry in 2024 due to a rise in research on new cancer drugs and therapies
- The oral solids dosage form segment is anticipated to witness the fastest growth rate during the forecast period
- By synthesis, the industry is classified into synthetic and biotech. The biotech segment is estimated to witness a significant growth rate from 2025 to 2030
- Asia-Pacific is estimated to register the fastest CAGR during the forecast period due to the presence of the largest manufacturers of APIs across the globe, such as China
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments
- Competitive Landscape: Explore the market presence of key players worldwide
- Future Trends: Discover the pivotal trends and drivers shaping the future of the global market
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions
This report addresses:
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listing for you to stay ahead of the curve
The leading players in the High Potency API Contract Manufacturing market include:
- Piramal Pharma Solutions
- Lonza
- Catalent, Inc.
- VxP Pharma, Inc.
- Pfizer CentreOne
- Gentec Pharmaceutical Group
- AbbVie
- Aurigene Pharmaceutical Services Ltd.
- CordenPharma International
- Curia Global, Inc.
Key Attributes
| Report Attribute | Details |
| No. of Pages | 130 |
| Forecast Period | 2024-2030 |
| Estimated Market Value (USD) in 2024 | $8.05 Billion |
| Forecasted Market Value (USD) by 2030 | $14.87 Billion |
| Compound Annual Growth Rate | 10.9% |
| Regions Covered | Global |
Key Topics Covered
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. High Potency API Contract Manufacturing Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.3. Market Analysis Tools
Chapter 4. High Potency API Contract Manufacturing Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Global High Potency API Contract Manufacturing Market; Product Movement Analysis
4.3. Global High Potency API Contract Manufacturing Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
4.4. Innovative
4.5. Generic
Chapter 5. High Potency API Contract Manufacturing Market: Application Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Global High Potency API Contract Manufacturing Market; Application Movement Analysis
5.3. Global High Potency API Contract Manufacturing Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
5.4. Oncology
5.5. Hormonal Disorders
Chapter 6. High Potency API Contract Manufacturing Market: Synthesis Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Global High Potency API Contract Manufacturing Market; Synthesis Movement Analysis
6.3. Global High Potency API Contract Manufacturing Size & Trend Analysis, by Synthesis, 2018 to 2030 (USD Million)
6.4. Synthetic
6.5. Biotech
Chapter 7. High Potency API Contract Manufacturing Market: Dosage Form Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Global High Potency API Contract Manufacturing Market; Dosage Form Movement Analysis
7.3. Global High Potency API Contract Manufacturing Size & Trend Analysis, by Dosage Form, 2018 to 2030 (USD Million)
7.4. Injectable
7.5. Oral Solids
7.6. Creams
7.7. Others
Chapter 8. High Potency API Contract Manufacturing Market: Regional Estimates & Trend Analysis
8.1. Regional Market Share Analysis, 2024 & 2030
8.2. Regional Market Dashboard
8.3. North America
8.4. Europe
8.5. Asia Pacific
8.6. Latin America
8.7. MEA
Chapter 9. Competitive Landscape
9.1. Company Categorization
9.2. Company Market Position Analysis, 2024
9.3. Company Profiles
For more information about this report visit https://www.researchandmarkets.com/r/svdl7w
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
